OQUEVO

LIVE

Serial Number

79303262

Owner

Mitsubishi Tanabe Pharma Corporation

Attorney

A. Tally Eitan

Filing Date

Dec 6, 2020

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OQUEVO Trademark

Serial Number: 79303262 • Registration: 6495771

OQUEVO is a trademark filed by Mitsubishi Tanabe Pharma Corporation on December 6, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Mitsubishi Tanabe Pharma Corporation

3-2-10, Dosho-machi,

Entity Type: 03

Tanabe Pharma Corporation

3-2-10, Dosho-machi,

Entity Type: 98

Legal Representation

Attorney of Record

A. Tally Eitan

1,830 trademarks filed View all →

Correspondence Address

A. Tally Eitan Eitan Mehulal Sadot

6480 Calverton Drive, Unit 202,

c/o Edna Eisemann

Frederick, MD 20874

UNITED STATES

Trademark Details

Filing Date

December 6, 2020

Registration Date

September 28, 2021

Published for Opposition

July 13, 2021

Goods & Services

Pharmaceutical preparations for the treatment of Parkinson's disease

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB

Mar 19, 2026 ADCH

NEW REPRESENTATIVE AT IB RECEIVED

Jul 30, 2022 NREP

FINAL DECISION TRANSACTION PROCESSED BY IB

Apr 4, 2022 FINV

FINAL DISPOSITION NOTICE SENT TO IB

Mar 16, 2022 FICS

FINAL DISPOSITION PROCESSED

Mar 16, 2022 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Dec 28, 2021 FICR

REGISTERED-PRINCIPAL REGISTER

Sep 28, 2021 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 13, 2021 NPUB

PUBLISHED FOR OPPOSITION

Jul 13, 2021 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 23, 2021 NONP

REFUSAL PROCESSED BY IB

Jun 20, 2021 RFNT

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 8, 2021 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 7, 2021 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 7, 2021 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 7, 2021 TROA

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 2, 2021 RFCS

REFUSAL PROCESSED BY MPU

Jun 2, 2021 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

May 29, 2021 RFCR

NON-FINAL ACTION WRITTEN

May 28, 2021 CNRT

ASSIGNED TO EXAMINER

May 25, 2021 DOCK

APPLICATION FILING RECEIPT MAILED

Feb 9, 2021 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 5, 2021 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 4, 2021 REPR

Related Trademarks

More from this Owner

TANABE PHARMA

TANAMIN

Serial #79438394

LIGHTMARE

More in Same Class

WHITECAT

WELEKE